Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment
about
Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeysParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisDisease-toxicant interactions in Parkinson's disease neuropathologyRecombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicityDrugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityChronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot StudyApocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERKSingle nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder.Pleiotrophin regulates microglia-mediated neuroinflammation.Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine.Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.Parkinson's disease managing reversible neurodegeneration.Which medications are suitable for agonist drug maintenance?Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.Structural abnormality of substantia nigra induced by methamphetamine abuse.The neurochemical consequences of methamphetamine self-administration in male and female rats.The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.Brain Microstructure and Impulsivity Differ between Current and Past Methamphetamine Users.Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats.Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.Behavior of α-synuclein-drug complexes during nanopore analysis with a superimposed AC field.Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.Self-administration of methamphetamine alters gut biomarkers of toxicity.The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.
P2860
Q27305163-9D81DB18-D515-4A30-AC59-9091CAA61A0EQ28384572-D08AA87C-7B1C-4ED2-B924-37916435E708Q29248297-D0A73685-A822-4E64-9DFB-56CC29301D90Q33702977-4263EB89-BD9C-4BFB-93A4-77C620EC23D3Q34504916-2E40EF3B-A7DB-44A8-A746-FB0C3491B108Q34673305-26FEEBE8-BAC5-4319-8DFB-7A0A96E84650Q35810975-CF832B3A-761D-477A-BE9D-BB65391872FFQ36316462-9D9343E0-B2A7-4A43-9F3F-93FCA39319DBQ36387048-D7BC1F3C-B3C9-47EB-A14D-626D677A34CCQ36476821-0F590C90-1409-42B4-8BAA-FB3D7475591DQ37316136-73236368-0E6C-4DE1-B3AA-5420799C3201Q37680127-F34992EF-5A24-4118-9525-6BB3E98C26C3Q38731675-3FADE8CC-AD2B-4D03-91A2-05D722CD57BEQ38744676-7A450387-2479-4674-A38B-FF38C92EC3B7Q38838536-D10B604A-3189-44D2-B6C0-CB6035B527CFQ38917424-9C81B89A-09D2-4541-A6DA-57D72E00EAA8Q38926228-2FE9D6E8-9ADE-4EF7-8240-9DF6E9D9282AQ39043765-56406448-58F3-4920-9EEA-93A8E649ACE4Q39153958-A75A27D2-CACF-4F2C-8339-03E3CA0FB6E4Q39356354-CF4D4D4F-D7EE-48BD-B1BC-1984D85E368CQ40030359-F49D25B3-03FD-40D9-9282-77EE91BB3FFCQ40390581-58AC41B6-D235-494E-8C2E-3636B8CE6FC4Q40983371-A348982A-6CFD-4DD6-9C16-6D52DC3A16C0Q42220091-59B3EE40-7E37-4298-87B6-194AD8185E8CQ46429572-B150BCDA-867E-420C-B2F1-3DC4176585B8Q47693643-31BD9E86-F9CF-497C-AE0A-7E0FB935B36DQ47720605-99653934-8859-4707-A052-7FD746F6A74CQ47845016-27A3D79C-C092-4163-B2BD-7B4E53DC2FADQ48056568-76983900-3B1F-4F8F-B95A-99F58C2B73ADQ48171776-9EB73D56-86F9-437F-8CC5-731523D1E2C8Q48184416-ACEB9491-C543-4B19-801A-4B4D8A00F7FAQ48302266-42BAB483-F64C-4EA1-B4AD-E5A3EEC46D1DQ51545497-B39FC29A-E930-4FA4-BDA4-3772A8829C8BQ52148359-C37BDACD-9A4C-4D56-9941-910CE741D513Q52313428-33D0FB13-9853-469D-92E6-881B218969C8Q55284097-63E72942-8110-4DAB-8433-11C870191048
P2860
Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Methamphetamine/amphetamine ab ...... a population-based assessment
@ast
Methamphetamine/amphetamine ab ...... a population-based assessment
@en
Methamphetamine/amphetamine ab ...... a population-based assessment
@nl
type
label
Methamphetamine/amphetamine ab ...... a population-based assessment
@ast
Methamphetamine/amphetamine ab ...... a population-based assessment
@en
Methamphetamine/amphetamine ab ...... a population-based assessment
@nl
prefLabel
Methamphetamine/amphetamine ab ...... a population-based assessment
@ast
Methamphetamine/amphetamine ab ...... a population-based assessment
@en
Methamphetamine/amphetamine ab ...... a population-based assessment
@nl
P2093
P2860
P1476
Methamphetamine/amphetamine ab ...... a population-based assessment
@en
P2093
Annette E Fleckenstein
Glen R Hanson
Karen Curtin
Ken R Smith
Michael J Crookston
Reid J Robison
P2860
P356
10.1016/J.DRUGALCDEP.2014.10.027
P577
2014-11-16T00:00:00Z